391 results on '"giant cell arteritis"'
Search Results
2. The role of 18FDG–PET imaging in VEXAS syndrome: a multicentric case series and a systematic review of the literature
3. The impact of histopathological criteria for definite vasculitis in giant cell arteritis: retrospective analysis of temporal artery biopsies
4. Clinical features, imaging use, and management in giant cell arteritis: a retrospective single-center study
5. Predictive biomarkers of response to tocilizumab in giant cell arteritis (GCA): correlations with imaging activity
6. Optic nerve sheath measurement to monitor disease activity in giant cell arteritis: a pilot study
7. Faster steroid-free remission with tocilizumab compared to methotrexate in giant cell arteritis: a real-life experience in two reference centres
8. Clinical Manifestations and Prognosis of Giant Cell Arteritis: A Retrospective Cohort Study
9. Temporal arteritis: iconodiagnosis in two 16th-century works of art, and a brief review of the medical and artistic literature
10. Cranial and extracranial manifestations of giant cell arteritis: a single-center observational study
11. Reproducibility and accuracy of vessel wall MRI in diagnosing giant cell arteritis: a study with readers of varying expertise
12. Entzündliche Ursachen von Schlaganfällen – Diagnostik und Therapie
13. Updates in the Management of Giant Cell Arteritis
14. Unklare Ursache einseitiger Erblindung bei normwertigen Entzündungsparametern
15. Giant cell arteritis: insights from a monocentric retrospective cohort study
16. Diagnostic delays in systemic vasculitides
17. Temporal arteritis presenting as third nerve palsy - a case report and review of literature
18. Zungennekrose als klinische Manifestation einer Riesenzellarteriitis
19. Glucocorticoid discontinuation rate and risk factors for relapses in a contemporary cohort of patients with giant cell arteritis
20. Giant cell arteritis as a cause of extracranial internal carotid artery aneurysm: a case report
21. Association between diabetes mellitus and giant cell arteritis: a bidirectional 2-sample mendelian randomization study
22. Antiplatelet therapy to prevent ischemic events in giant cell arteritis: protocol for a systematic review and meta-analysis
23. Evaluation of the extracranial “multifocal arcuate sign,” a novel MRI finding for the diagnosis of giant cell arteritis, on STIR and contrast-enhanced T1-weighted images
24. Effectiveness of janus kinase inhibitors in relapsing giant cell arteritis in real-world clinical practice and review of the literature
25. Surgical and endovascular cerebral revascularization for cerebral vasculitis with inflammatory vessel stenosis: a case series
26. Apolipoproteins and the risk of giant cell arteritis—a nested case–control study
27. The Meteoritics Trial: efficacy of methotrexate after remission-induction with tocilizumab and glucocorticoids in giant cell arteritis—study protocol for a randomized, double-blind, placebo-controlled, parallel-group phase II study
28. Step forward towards treat-to-target management of giant cell arteritis: patients stratification aiming to targeted remission – updated guidelines
29. Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome presenting as recurrent aseptic peritonitis in a patient receiving peritoneal dialysis: a case report
30. Usefulness of 18F-FDG PET-CT for assessing large-vessel involvement in patients with suspected giant cell arteritis and negative temporal artery biopsy
31. Predominance of T-bet-positive Th1 cells in infiltrating T-lymphocytes in most of active arteritis lesions of giant cell arteritis
32. Concomitant Polymyalgia Rheumatica and Giant Cell Arteritis Associated with Cystic Echinococcosis: A Rare Geriatric Case
33. Polymyalgia rheumatica – eine Herausforderung in der Altersmedizin: Diagnostik und Therapie interdisziplinär dargestellt
34. Trends in health care of patients with vasculitides, including giant cell arteritis, Takayasu arteritis, ANCA-associated vasculitis and Behçet’s disease: cross-sectional data of the German National Database 2007–2021
35. The role of color doppler ultrasonography in the diagnosis of giant cell arteritis in ophthalmic patients
36. The impact of month and season on the incidence of giant cell arteritis: an Intelligent Research in Sight (IRIS) Registry analysis
37. Diagnostik und Therapie von Großgefäßvaskulitiden
38. Aortitis – Diagnostik, Differenzialdiagnosen und Therapie
39. Polymyalgia rheumatica – eine Herausforderung in der Altersmedizin: Diagnostik und Therapie interdisziplinär dargestellt
40. Diagnostic delay in patients with giant cell arteritis: results of a fast-track clinic
41. Assessment and comparison of probability scores to predict giant cell arteritis
42. PET FDG CT is useful for giant-cell arteritis with isolated cough
43. Development of outcome measures for giant cell arteritis for use in clinical trials and standard practice
44. Orbital magnetic resonance imaging of giant cell arteritis with ocular manifestations: a systematic review and individual participant data meta-analysis
45. Clinical, laboratory and ultrasonographic findings at baseline predict long-term outcome of polymyalgia rheumatica: a multicentric retrospective study: Polymyalgia rheumatica predicted by ultrasonographic findings polymyalgia rheumatica outcome predicted early by ultrasound
46. Bildgebung bei Großgefäßvaskulitiden
47. Giant cell arteritis: the skin as the key to the diagnosis
48. Polymyalgia rheumatica – eine Herausforderung in der Altersmedizin: Diagnostik und Therapie interdisziplinär dargestellt
49. Incidental findings on FDG-PET/CT in large vessel vasculitis
50. Oral or pulse glucocorticoid use at the onset of giant cell arteritis and its influence on the risk of relapse: a retrospective study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.